The Value of Stereotactic Biopsy of Primary and Recurrent Brain Metastases in the Era of Precision Medicine
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
Frequency and prognostic relevance of volumetric MRI changes in contrast- and non-contrast-enhancing tumor compartments between surgery and radiotherapy of IDHwt glioblastoma